6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Anxiety in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antropova, NV; Kustikova, IN; Moiseeva, IIa; Rodina, OP; Vodop'ianova, OA | 1 |
| Faizullin, RM; Kalugina, AV; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, LA | 1 |
2 other study(ies) available for 6-methyl-2-ethyl-3-hydroxypyridine and Anxiety
| Article | Year |
|---|---|
[The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
Topics: Animals; Anxiety; Disease Models, Animal; Drug Combinations; Dyslipidemias; Emotions; Flavin Mononucleotide; Inosine Diphosphate; Male; Niacinamide; Picolines; Rats; Succinates | 2014 |
[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].
Topics: Animals; Anti-Anxiety Agents; Anxiety; Depression; Diabetes Mellitus, Experimental; Humans; Hyperglycemia; Meglumine; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid | 2015 |